Veloce BioPharma LLC   Report issue

For profit Phase 2
Founded: Fort Lauderdale FL United States (2015)
Status: No NME R&D (2015)

Organization Overview

First Clinical Trial
2017
NCT03077750
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Veloce BioPharma LLC

Active Ingredients

Drugs in Phase 2 Trials (2)

povidone-iodine (1 trial)

vbp-245 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Molluscum Contagiosum (Phase 2)

Paronychia (Phase 2)

Warts (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2